Stock listing

MRK Stock Price, News, Filings & Events — Merck & Company, Inc.

Selected listing: MRK · NEO · CAD · CA

This page tracks Merck & Company, Inc.'s MRK:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRK:NEO. MRK:NEO is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.

MRK:NEOCADCAUpdated July 31, 2026
Merck & Company, Inc. logo
Ticker
MRK:NEO
Asset type
Stock
Market cap
$321.57B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NEO
Currency
CAD

Merck & Company, Inc. MRK:NEO stock context

This page tracks Merck & Company, Inc.'s MRK:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRK:NEO. MRK:NEO is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.

Research Merck & Company, Inc.

Alternate listings